Immatics at the Tumor Targeted Lymphocyte Summit (Dec 11-13) in Boston, MA

| News, USA

The Tumor Targeted Lymphocyte Summit is bringing together for the first time the expert TIL and CTL community in Boston (Dec 11-13) and Immatics is part of it! Learn about strategies to expand TIL and CTL cells to increase efficacy of adoptive cell therapy in solid tumors. Thus don’t miss Geoffrey Stephens, Director Product Science, and his talk:

 

December 13th, 10:10am-10:40am

"Tracking the Fate of ACTolog T Cells in a Phase 1 Oncology Clinical Study

Speaker: Geoffrey Stephens (Director Product Science)

Session: "Current Clinical & Translational Updates"

 

We're looking forward to interesting and exciting discussions. 

Further information about the Tumor Targeted Lymphocyte Summit here.

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back